summarized the progressive research experience of that time, testifying to the high level of Russian surgery in the 19th century. The results of using ordinary modeling/candle wax were not optimal, however, given the lack of sterility and malleability of the wax. It is quite interesting to note that this technique was described a full 50 years before Horsley's description in the the British Medical Journal.
In addition to Russia's contribution to the use of wax to control hemostasis after cranial surgery, anatomists and clinicians in France had applied the use of wax for hemostasis in the mid-19th century. First, François Magendie (1783-1855) used wax to close venous sinuses 9, 25 in his experimental animal models, and his method subsequently passed into the operative suite. Horsley specifically mentions this event as a primary influence in his introduction of bone wax into the nascent field of neurosurgery.
Interestingly, Henri Ferdinand Dolbeau (1840-1877), a distinguished French surgeon, in 1864 was one of the first physicians to operate successfully on an osteoma of the frontal sinus. In a report delivered by Richet 5, 19, 25 in 1871 at the meeting of the Paris Academy of Medicine on "Dolbeau's lecture on the exostoses of the frontal sinus," which had been read at the Academy of Medicine in September 1866, it was stated: "we were obliged to play with a ball of wax in the orifice of a major artery lying on the surface where the tumor was implanted which gushed blood." Dolbeau's operation in 1864 dates back to a time when Victor Horsley, who was born in 1857, was only 7 years old, 16, 25, 26 and in his publication Dolbeau describes having used wax for hemostasis during extirpation of this lesion with good results (Fig. 1) . Consequently, it has been noted that Dolbeau preceded Horsley in the use of bone wax by several years, 24, 25 a fact that is recognized by Bucy 3 in an editorial note. In his 1896 book A Treatise on Surgery, Roswell Park writes, "a number of years ago, Gunn suggested the use of wax for this (stopping bleeding from bone) purpose,... being plastic and incapable of absorption. A piece of white wax was heated in hot water, molded with the fingers to fit the cavity, where it served the purpose of a packing." 17 This description also suggests that the use of wax for hemostasis occurred several years prior to Horsley's description.
Horsley's Contribution
Sir Victor Alexander Haden Horsley, regarded by many as one of the founders of British neurosurgery, was appointed to the Brown Institution of the University of London in 1884, where he performed extensive experiments on the localization of brain function. Horsley conducted his own experiments on the cranial bones of dogs but was dissatisfied with the results, and thus he asked P. W. Squire to assist him. It was Squire who came up with the formula of using beeswax instead of ordinary modeling wax in a preparation that later came to be called "bone wax." The material was kept in stoppered bottles and was sterilized by boiling. 7 The first documented evidence of the successful use of bone wax in clinical surgery appeared in the May 21, 1892, edition of the British Medical Journal; Rushton Parker used it to stop bleeding from the lateral sinus. 18 In his paper, he gives thorough credit to Victor Horsley for providing the wax (Fig. 2) : "The lateral sinus was scraped, and sublimate solution syringed freely through the sinus, and the stump of the jugular vein and other exposed parts. On probing the sinus upwards, blood flowed freely, but was easily stopped with a plug of antiseptic wax (of composition unknown to me, but kindly provided by Mr. Victor Horsley and Messrs. Squire)."
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When asked to comment, Horsley 9 wrote in his correspondence, which was published in the May 28, 1892, volume:
Sir, The antiseptic wax which Mr. Rushton Parker refers to on page 1076 of the British Medical Journal of May 21st has the following composition: beeswax, 7 parts; almond oil, 1 part; salicylic acid, 1 per cent. It is the outcome of experiments made in 1885, when, remembering the practice of Magendie and others at the commencement of the century in stopping the sinuses with wax, I tried the effect of "smudging" modelling wax worked soft in the fingers on the free bleeding cut surface of the cranial bones in dogs. As such a process instantly arrested the bleeding, I tried to make an antiseptic compound for operations on man, and the formula was published. It was not, however, satisfactory in my opinion, and I asked Mr. P. W. Squire kindly to make experiments so as to arrive nearly at the tenacity of modelling wax. This, I think, he has perfectly succeeded in with the above formula. I have very often used it, and without the least inconvenience. I need hardly say that it is always sterilised by boiling before use, and kept in covered stoppered bottles.-I am, etc.
This brief communication by Horsley became the source for his subsequent credit for the invention of bone wax. Indeed, M. Allen Starr's 23 textbook on brain surgery, published 1 year after Horsley's description, specifically refers to "Horsley's wax" as the material to use in situations of diploic bleeding refractory to gentle pressure. Interestingly, he also lists alternative means to hemostasis in this description, including local pressure with a sponge, a plug of decalcified bone, a plug made from an aseptic sponge, or direct crushing of the inner and outer tables directly on the diploic vein.
Despite its popularity, Horsley's bone wax was not free from complications. Bone wax was noted to potentially cause chronic inflammation, 2,7,10 act as a mechanical barrier to bone regeneration, 1, 20, 22 lower the bacterial clearance in cancellous bone, precipitate the formation of a foreign body granuloma, 13 and migrate into the sigmoid sinus. 8 Concerns over these undesirable properties prompted research into the development of alternative hemostatics. 15 In 1900 Crile 4 proposed a modification to Horsley's formula. Fifty years later, Geary and Frantz 7 described a resorbable polyethylene glycol composite as a vehicle to deliver a hemostatic agent-oxidized cellulose. Instead of beeswax, they used carbowax. They compared their material to original bone wax in a rib fracture model. Polyethylene glycol-tamponaded bleeding bone was resorbed and caused only a minor inflammatory reaction. Of historical importance is the fact that today's bone wax, which is made of 88% refined beeswax and 12% isopropyl palmitate, is remarkably similar to that developed by Squire and Horsley.
Conclusions
Technology and innovation builds on the successes and failures of the past. The use of bone wax in neurosurgery was certainly popularized by Horsley's timely contribution to the literature. The debates regarding the first use of bone wax in neurosurgery may continue, as they do in trying to determine whether Horsley or Cushing was the first to use muscle as a hemostatic agent. However, there is pervasive evidence that the use of bone wax to achieve hemostasis in bone was not conceived by Horsley, who himself points to earlier pioneers such as Magendie and Gunn as specific influences for this idea. 
